Specialized Pilocarpine Formulations for Niche Environments

Publication ID: 24-11857538_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Pilocarpine Formulations for Niche Environments,” Published Technical Disclosure No. 24-11857538_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857538_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,538.

Summary of the Inventive Concept

The present inventive concept relates to adapted pilocarpine formulations and systems tailored for specific, challenging operational environments, such as high-altitude, disaster relief, compromised immune systems, extreme cold weather, and remote areas.

Background and Problem Solved

The original patent disclosed stable pilocarpine formulations with modified buffer characteristics for treating ophthalmic conditions. However, these formulations may not be suitable for unique operational environments, such as high-altitude or disaster relief situations, where specific requirements and constraints apply. The present inventive concept addresses these limitations by adapting the pilocarpine formulations to meet the specific needs of these niche environments.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of specialized pilocarpine formulations and systems designed to operate effectively in challenging environments. For instance, a system for treating ophthalmic conditions in high-altitude environments comprises a reduced buffer content composition with a pH range of about 4.5 to about 5.5, and a container adapted for use in low-oxygen conditions. Similarly, a method for providing emergency eye care in disaster relief situations involves administering a pharmaceutically acceptable and ophthalmologically suitable reduced buffer content composition to a patient in need thereof, wherein the composition is stored in a portable, waterproof container. Other embodiments include kits for treating presbyopia in individuals with compromised immune systems, compositions for treating ophthalmic conditions in extreme cold weather environments, and portable, self-contained ophthalmic treatment systems for use in remote or extreme weather environments.

Novelty and Inventive Step

The present inventive concept introduces novel and non-obvious adaptations of pilocarpine formulations to address the specific challenges of niche environments. The inventive step lies in the combination of the original pilocarpine formulation with specialized components, containers, and systems tailored to meet the unique requirements of these environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include additional components, such as UV protection or anti-microbial agents, to further enhance the formulations' performance in challenging environments. Variations of the systems and methods could be designed for other niche environments, such as high-humidity or high-temperature settings.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the ophthalmic industry, particularly in the areas of disaster relief, remote healthcare, and specialized medical services. The adapted pilocarpine formulations and systems could be marketed to organizations and governments involved in disaster response, remote medical care, and specialized healthcare services.

Field of Art

Pharmaceutical formulations, specifically ophthalmic drug compositions for treating presbyopia, with expertise in solution chemistry, buffer systems, and drug stability

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical scientist or formulation chemist with advanced degree, experience in ophthalmologic drug development, understanding of pH stability, buffer interactions, and environmental adaptation of pharmaceutical compositions

Obviousness Rationale

A PHOSITA would recognize that the source patent's pilocarpine formulation provides a foundational framework for environmental adaptations. The PTD's variations represent predictable extensions of known pharmaceutical engineering principles, applying standard techniques for modifying drug delivery systems to address specific environmental challenges. The core composition remains substantially similar, with incremental modifications that would be obvious to a skilled practitioner seeking to optimize drug performance in diverse conditions.

Obvious Combinations & Variations

Source Patent Element
Reduced buffer content composition with pH between 3 and 6
PTD Variation
Narrowing pH range to 4.5-5.5 for high-altitude and extreme environment applications
Obviousness Reasoning
Routine optimization of known pH range, predictable result of maintaining drug stability across different environmental conditions
Source Patent Element
Pilocarpine hydrochloride at 1.25% w/v concentration
PTD Variation
Slight concentration adjustment to 1.5% w/v for compromised immune system patients
Obviousness Reasoning
Minor concentration modifications are standard pharmaceutical design practice, representing an obvious variation to adjust therapeutic efficacy
Source Patent Element
Pharmaceutically acceptable ophthalmic solution
PTD Variation
Specialized containers and delivery systems for disaster relief, remote, and extreme environments
Obviousness Reasoning
Adapting standard pharmaceutical formulations to specific use cases represents a known technique in drug delivery system engineering
Source Patent Element
Stable pilocarpine composition maintaining compound integrity
PTD Variation
Adding preservative systems and protective casings for temperature and environmental resistance
Obviousness Reasoning
Implementing standard protective techniques to extend drug stability is a predictable solution for challenging environmental conditions
Source Patent Element
Basic ophthalmic composition for presbyopia treatment
PTD Variation
Developing targeted kits for specific patient populations with specialized applicator devices
Obviousness Reasoning
Tailoring pharmaceutical delivery to specific patient needs represents an obvious design choice within pharmaceutical product development
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857538, the variations disclosed herein would be obvious to a Person Having Ordinary Skill In The Art, as they represent predictable extensions of known pharmaceutical formulation techniques. The incremental modifications to pilocarpine compositions, including environmental adaptations, concentration adjustments, and specialized delivery systems, do not rise to the level of non-obvious innovation when viewed in light of the prior art.

Original Patent Information

Patent NumberUS 11,857,538
TitleStable pilocarpine formulations with modified buffer characteristics and related methods
Assignee(s)Somerset Therapeutics, LLC